Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies

Experimental Gerontology

Volumn 35, Issue 9-10, 2000, Pages 1353-1361

  Bertram, L ^a   Blacker, D ^a,b   Crystal, A ^a   Mullin, K ^a   Keeney, D ^a   Jones, J ^a   Basu, S ^a   Yhu, S ^a   Guenette S ^a   McInnis, M ^c   Go, R ^d   Tanzi, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alzheimer genetics; Candidate genes; Family based association tests; Linkage studies

Indexed keywords

CATHEPSIN D; CHOLINESTERASE; INTERLEUKIN 1BETA; LIPOPROTEIN RECEPTOR RELATED PROTEIN 1; NERVE PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANALYTIC METHOD; CHROMOSOME 11P; CHROMOSOME 12; CHROMOSOME 2P; CHROMOSOME 3Q; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BUTYRYLCHOLINESTERASE; CATHEPSIN D; FAMILY HEALTH; GENE FREQUENCY; GENES; GENOTYPE; HUMANS; INTERLEUKIN-1; LDL-RECEPTOR RELATED PROTEIN 1; LINKAGE DISEQUILIBRIUM; NERVE TISSUE PROTEINS; NUCLEAR FAMILY; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; STATISTICS, NONPARAMETRIC;

EID: 0033654196     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(00)00193-5     Document Type: Conference Paper

References (37)

1. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites
2. No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer's disease
3. The genetics of Alzheimer disease: Current status and future prospects
4. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
5. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
6. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease
7. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis
8. Cathepsin D displays in vitro beta-secretase-like specificity
9. The butyrylcholinesterase gene is neither independently nor sysnergistically associated with late-onset AD in clinic- and community-based populations
10. The number of trait loci in late-onset Alzheimer disease
11. Single base polymorphism at -511 in the human interleukin-1b gene (IL1b)
12. No association between the low density lipprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample
13. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
14. Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients
15. Association of early-onset Alzheimer's disease with an inter leukin-1alpha gene polymorphism
16. A polymorphic DNA marker genetically linked to Huntington's disease
17. A discordant-sibship test for disequilibrium and linkage: No need for parental data
18. The human FE65 gene: Genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type
19. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site
20. Genetic association of the low-density lopoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease
21. Identification of the cystic fibrosis gene: Genetic analysis
22. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation
23. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease
24. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease
25. Inflammation and Alzheimer's disease
26. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease
27. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease
28. Complete genomic screen in late-onset familial Alzheimer's disease
29. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein
30. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
31. Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein
32. Association of apolipoprotein E allele epsilon4 with late-onset familial and sporadic Alzheimer's disease
33. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction - Single strand conformations polymorphism analysis and possible consequence in cancer cells
34. LRP gene and late-onset Alzheimer's disease